Ireson, Christopher R.
Alavijeh, Mo S.
Palmer, Alan M.
Fowler, Emily R.
Jones, Hazel J.
Article History
Received: 28 August 2018
Revised: 9 May 2019
Accepted: 16 May 2019
First Online: 24 June 2019
Competing interests
: Drs. Alavijeh and Ireson are employees of Pharmidex Pharmaceutical Services Limited. Dr. Jones is an employee of AstraZeneca. Professor Alan Palmer is a visiting professor at the University of Reading. Ms. Fowler, a doctoral student, is funded by the BBSRC. The authors do not declare any other conflicts of interest.
: Not applicable.
: Drs. Alavijeh, Ireson and Jones are funded directly by their employers. Ms. Fowler is funded by the BBSRC.
: Not applicable.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).